BEAMSTART Logo

HomeNews

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Wired LogoWired11h ago

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired

Quick Summary:

Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Hornung says that companies continuing to sell tirzepatide are hoping the vitamin additives and other tweaks will allow them to argue they aren’t selling straightforward copies of Lilly’s patented drugs.“They’re getting very creative,” she says.

The pharmaceutical giant’s lawsuit against Henry Meds, which offers oral and injectable GLP-1 medications, accuses the company of “creating the false impression” that clinical trials have confirmed the effectiveness of its drugs, “materially omitting that no such clinical trial data exists.

More Pictures

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired (Picture 1)Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired (Picture 2)Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired (Picture 3)Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired (Picture 4)Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs - Wired (Picture 5)

or

Article Details

Author / Journalist: Kate Knibbs, Emily Mullin

Category: TechnologyEconomy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-23 @ 09:00:00 (11 hours ago)

News Timezone: GMT +8:00

News Source URL: wired.com

Language: English

Article Length: 1758 words

Reading Time: 10 minutes read

Sentences: 72 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Wired

News ID: 28168566

View Article Analysis

About Wired

Main Topics: TechnologyEconomy

Official Website: wired.com

Update Frequency: 10 posts per day

Year Established: 1993

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #111

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs" has 1758 words across 72 sentences, which will take approximately 8 - 15 minutes for the average person to read.

Which news outlet covered this story?

The story "Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs" was covered 11 hours ago by Wired, a news publisher based in United States.

How trustworthy is 'Wired' news outlet?

Wired is a fully independent (privately-owned) news outlet established in 1993 that covers mostly technology and economy news.

The outlet is headquartered in United States and publishes an average of 10 news stories per day.

It's most recent story was published 8 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #28168566
  • URL: https://citrocola.beamstart.com/news/eli-lilly-sues-4-glp-17453998482733

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2025 BEAMSTART. All Rights Reserved.